Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Acupuncture for Treating Nausea & Vomiting
Author
Howard (Jack) West, MD

I reviewed a few general principles of acupuncture in my last post on its use for pain control. In addition, acupuncture has also been studied as a potential treatment modality for other nausea/vomiting, with some evidence to support its use in addition to anti-nausea (also called antiemetic) medications. Current ACCP guidelines (abstract here, again) strongly recommended acupuncture as a treatment for nausea and vomiting associated with chemo if these symptoms are not well controlled or when side effects from other treatments are problematic. The data aren't overwhelming, but the recommendation is largely based on acupuncture having very minimal potential adverse effects, so even modest/inconsistent benefits would be felt to outweigh the very slight risk.

A study in the setting of breast cancer (abstract here) randomized patients to receive electroacupuncture to a couple of relevant points, minimal needling at non-acupuncture sites ("sham" acupuncture, a form of placebo control), or anti-nausea medications with no attempted acupuncture, real or otherwise. Electroacupuncture reduced total vomiting episodes from 15 to 5 (median), compared to medications alone, while minimal needling produced results between the full treatment and medications alone (median 10 vomiting episodes).

Studies combining acupuncture with newer generation anti-nausea medications like serotonin receptor blockers (current staples like zofran, kytril, and anzamet, all very similar to each other) have been inconclusive. In a study of patients without cancer but with a form of rheumatic disease that required the chemo medication methotrexate), the combination of acupuncture at the PC6 acupuncture point above the wrist and zofran worked better than zofran alone (full text here). On the other hand, another study that compared zofran and acupuncture at the PC6 point to zofran with sham acupuncture (without penetrating skin) showed no real contribution from acupuncture (abstract here). Other studies demonstrate that acupuncture can reduce nausea/vomiting associated with recent surgery (abstract here) motion sickness (abstract here), and pregnancy (abstract here).

There was a recent meta-analysis of over 1200 patients from 11 trials of various modalities that included acupuncture, acupressure, electroacupuncture, and non-invasive electrostimulation of overlying skin (abstract here). Although not especially dramatic, all of these modalities except non-invasive electrostimulation was associated with some improvement in acute, but not delayed, vomiting.

Overall, the benefits of acupuncture have been rather subtle, but it appears to be an approach that may provide some modest added benefit over medications alone. One interpretation of the negative results in the setting of a bone marrow transplant is that acupuncture may be helpful for more moderate nausea/vomiting challenges, but it may not be effective enough in the setting of very severe anticipated nausea/vomiting. Regardless, these results were enough to have the ACCP say that acupuncture merits consideration as a treatment strategy for nausea/vomiting.

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on